Cargando…
Alpha synuclein in hematopoiesis and immunity
Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neuron...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806402/ https://www.ncbi.nlm.nih.gov/pubmed/31692680 http://dx.doi.org/10.1016/j.heliyon.2019.e02590 |
_version_ | 1783461620418084864 |
---|---|
author | Pei, Yu Maitta, Robert W. |
author_facet | Pei, Yu Maitta, Robert W. |
author_sort | Pei, Yu |
collection | PubMed |
description | Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neurons but can also be found in a number of tissues. It can be present as a soluble monomer under normal physiological conditions, but can be toxic in its oligomeric or fibrillary forms. Most of the available literature has focused on the effects of α-syn pathology in the mechanisms leading to PD. However, the normal functions of α-syn still remain to be fully elucidated. Notably, α-syn in the hematopoietic system seems to mediate important functions as indicated by anemia and incomplete cell maturation when this protein is absent. This review will summarize basic genetic and structural findings, and critical information that suggests an essential role of α-syn in the development and activation of the hematopoietic system and immunity. |
format | Online Article Text |
id | pubmed-6806402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68064022019-11-05 Alpha synuclein in hematopoiesis and immunity Pei, Yu Maitta, Robert W. Heliyon Article Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neurons but can also be found in a number of tissues. It can be present as a soluble monomer under normal physiological conditions, but can be toxic in its oligomeric or fibrillary forms. Most of the available literature has focused on the effects of α-syn pathology in the mechanisms leading to PD. However, the normal functions of α-syn still remain to be fully elucidated. Notably, α-syn in the hematopoietic system seems to mediate important functions as indicated by anemia and incomplete cell maturation when this protein is absent. This review will summarize basic genetic and structural findings, and critical information that suggests an essential role of α-syn in the development and activation of the hematopoietic system and immunity. Elsevier 2019-10-18 /pmc/articles/PMC6806402/ /pubmed/31692680 http://dx.doi.org/10.1016/j.heliyon.2019.e02590 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Pei, Yu Maitta, Robert W. Alpha synuclein in hematopoiesis and immunity |
title | Alpha synuclein in hematopoiesis and immunity |
title_full | Alpha synuclein in hematopoiesis and immunity |
title_fullStr | Alpha synuclein in hematopoiesis and immunity |
title_full_unstemmed | Alpha synuclein in hematopoiesis and immunity |
title_short | Alpha synuclein in hematopoiesis and immunity |
title_sort | alpha synuclein in hematopoiesis and immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806402/ https://www.ncbi.nlm.nih.gov/pubmed/31692680 http://dx.doi.org/10.1016/j.heliyon.2019.e02590 |
work_keys_str_mv | AT peiyu alphasynucleininhematopoiesisandimmunity AT maittarobertw alphasynucleininhematopoiesisandimmunity |